Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
26.05
+0.11 (0.40%)
Oct 9, 2025, 4:00 PM EDT - Market closed

FMED Holdings Information

FMED is an equity ETF with a total of 69 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 5.17%, Boston Scientific at 4.83%, argenx SE at 4.26%, UCB SA at 4.10%, and Fidelity Securities Lending Cash Central Fund at 3.71%.

Total Holdings
69
Top 10 Percentage
38.58%
Asset Class
Equity
ETF Category
Health
Assets
57.40M
PE Ratio
40.28

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1ALNYAlnylam Pharmaceuticals, Inc.5.17%6,504
2BSXBoston Scientific Corporation4.83%28,456
3ARGXargenx SE4.26%3,053
4EBR: UCBUCB SA4.10%7,942
5n/aFidelity Securities Lending Cash Central Fund3.71%2,129,842
6VEEVVeeva Systems Inc.3.55%6,875
7DHRDanaher Corporation3.51%9,358
8PODDInsulet Corporation3.29%6,098
9EXASExact Sciences Corporation3.11%31,440
10WAYWaystar Holding Corp.3.05%45,286
11PENPenumbra, Inc.2.80%6,264
12ISRGIntuitive Surgical, Inc.2.57%3,253
13LEGNLegend Biotech Corporation2.41%43,144
14MRUSMerus N.V.2.34%14,228
15EWEdwards Lifesciences Corporation2.33%17,372
16MASIMasimo Corporation2.18%8,500
17EPA: DIMSartorius Stedim Biotech S.A.2.15%5,276
18SYKStryker Corporation1.94%3,000
19LFSTLifeStance Health Group, Inc.1.90%197,894
20TMOThermo Fisher Scientific Inc.1.85%1,949
21UNHUnitedHealth Group Incorporated1.79%2,846
22COGTCogent Biosciences, Inc.1.65%60,000
23DOCSDoximity, Inc.1.65%12,895
24PCVXVaxcyte, Inc.1.60%21,545
25RMDResMed Inc.1.59%3,279
Showing 25 of 69 holdings
Subscribe to see the full list
As of Oct 3, 2025